- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Men with Low-Risk Prostate Cancer Receiving Unnecessary, Expensive Treatment
Men without low-risk prostate cancer have been found to be undergoing potentially unnecessary and expensive treatment. The instilled fee-for-service healthcare model is suggested a cause for blame in the rise of unnecessary tests. NBC News reports:
Despite new guidelines recommending “watchful waiting” for men diagnosed with prostate cancers that carry a low risk of death, more are undergoing potentially unnecessary, but expensive, treatment with high-tech machines according to a large study published Tuesday in the Journal of the American Medical Association (JAMA).
What to do about prostate cancer -- including whom to screen for it and when to treat, or not to treat, has long provoked controversy. The U.S. Preventive Services Task Force advises against routine screening for most men, and recommends active surveillance, not treatment, for men diagnosed with low-risk disease.
The study -- which concludes that “use of advance treatment technologies has increased” among low-risk patients -- found that between 2004 and 2009, use of robotic surgery and intensity-modulated radiotherapy (IMRT) both saw significant increases in men most experts regard as inappropriate candidates for such treatments.
Read the full story here: http://nbcnews.to/17cK6Fk
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
